Suppr超能文献

百日咳毒素催化性S-1亚基中的ADP-核糖基转移酶突变

ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin.

作者信息

Barbieri J T, Cortina G

机构信息

Department of Microbiology, Medical College of Wisconsin, Milwaukee 53226.

出版信息

Infect Immun. 1988 Aug;56(8):1934-41. doi: 10.1128/iai.56.8.1934-1941.1988.

Abstract

The ADP-ribosyltransferase activity of pertussis toxin resides within the S-1 subunit of the toxin. Deletion mapping of a recombinant S-1 subunit produced in Escherichia coli showed that amino acids 2 through 180 are required for ADP-ribosylation of Gi protein. Mutants of the S-1 subunit which lacked either amino acids 2 through 22 or amino acids 153 through 180 failed to express enzyme activity, implicating a functional or structural role for these residues in catalysis. The catalytic carboxy-terminal S-1 deletion, C-180, was found to be more soluble than the recombinant S-1 subunit, making it a useful construct for future structure-function studies on enzyme catalysis. Four independent single-amino-acid substitutions which decreased ADP-ribosyltransferase activity were constructed in the recombinant S-1 subunit. Substitution of Asp-11 by Ser, Arg-13 by Leu, or Trp-26 by Ile decreased enzyme activity to below detectable levels (less than 1.0% of that of the recombinant S-1 subunit). The Glu-139-to-Ser substitution reduced ADP-ribosyltransferase activity to 15% of that of the recombinant S-1 subunit. Both the oxidized and reduced forms of the recombinant S-1 subunit and recombinant S-1 subunits containing single-amino-acid substitutions were degraded through identical immunoreactive tryptic peptides, suggesting that the conformations of the mutants are similar to that of the recombinant S-1 subunit. Identification of noncatalytic forms of the S-1 subunit of pertussis toxin which have conserved protein structure is an initial step in the generation of a recombinant noncatalytic form of pertussis toxin which may be tested as a candidate for an acellular vaccine against Bordetella pertussis.

摘要

百日咳毒素的 ADP - 核糖基转移酶活性存在于毒素的 S - 1 亚基中。对在大肠杆菌中产生的重组 S - 1 亚基进行缺失作图表明,Gi 蛋白的 ADP - 核糖基化需要第 2 至 180 位氨基酸。缺少第 2 至 22 位氨基酸或第 153 至 180 位氨基酸的 S - 1 亚基突变体无法表达酶活性,这表明这些残基在催化中具有功能或结构作用。发现催化性羧基末端 S - 1 缺失体 C - 180 比重组 S - 1 亚基更易溶解,这使其成为未来酶催化结构 - 功能研究的有用构建体。在重组 S - 1 亚基中构建了四个降低 ADP - 核糖基转移酶活性的独立单氨基酸取代。将 Asp - 11 替换为 Ser、Arg - 13 替换为 Leu 或 Trp - 26 替换为 Ile 可使酶活性降至检测水平以下(低于重组 S - 1 亚基的 1.0%)。Glu - 139 替换为 Ser 可使 ADP - 核糖基转移酶活性降至重组 S - 1 亚基的 15%。重组 S - 1 亚基的氧化型和还原型以及含有单氨基酸取代的重组 S - 1 亚基均通过相同的免疫反应性胰蛋白酶肽段降解,这表明突变体的构象与重组 S - 1 亚基相似。鉴定具有保守蛋白质结构的百日咳毒素 S - 1 亚基的非催化形式是生成重组非催化形式百日咳毒素的第一步,该重组毒素可作为抗百日咳博德特氏菌无细胞疫苗的候选物进行测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72fb/259504/e4f55710decc/iai00080-0119-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验